SCHEMBL4425087

SCHEMBL4425087

CC(Cl)C=C(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11336501 0.88 LMNA (0.33)
Bicarbonate SCHEMBL11503246 0.88 LMNA (0.33)
SCHEMBL16022354 0.76
SCHEMBL322272 0.74
SCHEMBL11210690 0.73
SCHEMBL1638173 0.71
SCHEMBL10794031 0.71
SCHEMBL151237 0.69
SCHEMBL23373219 0.69
SCHEMBL4434131 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10427998-B2 Compositions based on 1,1,3,3-tetrachloropropene ARKEMA FRANCE (FR) 2019-10-01 US claimed
US-20260103554-A1 COMPOSITION KURARAY CO., LTD. (JP) 2026-04-16 US disclosed
EP-4603515-A1 COMPOSITION Kuraray Co., Ltd. (JP) 2025-08-20 EP disclosed
WO-2024080374-A1 COMPOSITION 株式会社クラレ 2024-04-18 WO disclosed
US-10427998-B2 Compositions based on 1,1,3,3-tetrachloropropene ARKEMA FRANCE (FR) 2019-10-01 US disclosed
US-20180148394-A1 COMPOSITIONS BASED ON 1,1,3,3-TETRACHLOROPROPENE ARKEMA FRANCE (FR) 2018-05-31 US disclosed
EP-3297981-A1 COMPOSITIONS BASED ON 1,1,3,3-TETRACHLOROPROPENE ARKEMA FRANCE (FR) 2018-03-28 EP disclosed
EP-3293170-A1 CHLOROALKENE PRODUCTION METHOD ACCOMPANIED WITH DEHYDROCHLORINATION REACTION Tokuyama Corporation (JP) 2018-03-14 EP disclosed
EP-0934311-B1 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER HEALTHCARE AG (DE) 2009-05-13 EP disclosed
EP-0934311-B1 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER HEALTHCARE AG (DE) 2009-05-13 EP disclosed
US-6387940-B1 CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6166027-A Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed
CN-1241188-A Heterocyclylmethyl-substed pyrazol derivs. BAYER AG (DE) 2000-01-12 CN disclosed
EP-0934311-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER AG (DE) 1999-08-11 EP disclosed
WO-1998016507-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO disclosed
EP-0399284-B1 Method for the production of geminal diarylalkanes, geminal diarylalkanes and alk(en)ylated aromatic compounds BAYER AG (DE) 1995-08-02 EP disclosed
US-5136114-A PROCESS FOR THE PREPARATION OF GEMINAL DIARYLALKANES, NEW GEMINAL DIARYLALKANES AND ALK(EN)YLATED AROMATIC COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1992-08-04 US disclosed
EP-0399284-A2 Method for the production of geminal diarylalkanes, geminal diarylalkanes and alk(en)ylated aromatic compounds BAYER AG (DE) 1990-11-28 EP disclosed
US-4492799-A INSECTICIDES, MITICIDES UNION CARBIDE CORPORATION (US) 1985-01-08 US disclosed
US-4338326-A PESTICIDES UNION CARBIDE CORPORATION (US) 1982-07-06 US disclosed